Literature DB >> 6134885

Diet and antibody response to vaccinations in healthy infants.

G Zoppi, R Gasparini, F Mantovanelli, L Gobio-Casali, R Astolfi, P Crovari.   

Abstract

Antibody responses to poliovirus, diphtheria, pertussis, or tetanus vaccine were compared in five groups of infants. The 62 infants had been brought up on breast milk or on one of four types of artificial feed in the first five months of life. The types of artificial feed varied in quality and quantity of protein; they were high or low protein cow's milk, an adapted formula (with a casein/albumin ratio of 40/60), and a formula based on soy flour. After the age of 5 months, all infants were put on the same diet. The general pattern of antibody responses as determined by antibody levels when the infants were 5 and 8 months old was that those fed on breast milk or high-protein cow's milk had adequate and sustained antibody responses; those fed on the adapted formula had a high but temporary response; and those fed on low-protein cow's milk or the soy-based formula had poor responses.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6134885     DOI: 10.1016/s0140-6736(83)90004-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  23 in total

1.  Enhancement of thyrocyte HLA class II expression by thyroid stimulating hormone.

Authors:  I Todd; R Pujol-Borrell; L J Hammond; J M McNally; M Feldmann; G F Bottazzo
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

Review 2.  NTP-CERHR expert panel report on the reproductive and developmental toxicity of soy formula.

Authors:  Karl K Rozman; Jatinder Bhatia; Antonia M Calafat; Christina Chambers; Martine Culty; Ruth A Etzel; Jodi A Flaws; Deborah K Hansen; Patricia B Hoyer; Elizabeth H Jeffery; James S Kesner; Sue Marty; John A Thomas; David Umbach
Journal:  Birth Defects Res B Dev Reprod Toxicol       Date:  2006-08

3.  Immunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy.

Authors:  A P Weetman; S Cohen; K C Gatter; P Fells; B Shine
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

4.  Expression of class II MHC antigens on alveolar epithelium in fibrosing alveolitis.

Authors:  C G Kallenberg; B M Schilizzi; F Beaumont; S Poppema; L De Leij; T H The
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

5.  Epithelial HLA-DR expression and T lymphocyte subsets in salivary glands in Sjögren's syndrome.

Authors:  G Lindahl; E Hedfors; L Klareskog; U Forsum
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

6.  HLA-A,B,C, HLA-D/DR and HLA-D/DQ expression on unfixed liver biopsy sections from patients with chronic liver disease.

Authors:  G Ballardini; F B Bianchi; R Mirakian; M Fallani; E Pisi; G F Bottazzo
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

7.  Immunocytochemical analysis of HLA class II (DR) antigens in liver disease in man.

Authors:  C Barbatis; P Kelly; J Greveson; A Heryet; J O McGee
Journal:  J Clin Pathol       Date:  1987-08       Impact factor: 3.411

8.  HLA-DR antigens on colonic epithelial cells in inflammatory bowel disease: I. Relation to the state of activation of lamina propria lymphocytes and to the epithelial expression of other surface markers.

Authors:  S Fais; F Pallone; O Squarcia; L Biancone; F Ricci; P Paoluzi; M Boirivant
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

9.  The remarkable proliferation of helper T cell subset in response to autologous thyrocytes and intrathyroidal T cells from patients with Graves' disease.

Authors:  K Eguchi; T Otsubo; Y Kawabe; Y Ueki; T Fukuda; M Matsunaga; C Shimomura; N Ishikawa; H Tezuka; H Nakao
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

10.  The sera of patients with Klebsiella infections contain a common anti-DNA idiotype (16/6) Id and anti-polynucleotide activity.

Authors:  A el-Roiey; O Sela; D A Isenberg; R Feldman; B C Colaco; R C Kennedy; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.